Nick Leschly
2019 - bluebird bio
In 2019, Nick Leschly earned a total compensation of $13.2M as Chief Executive Officer at bluebird bio, a 45% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $418,275 |
---|---|
Option Awards | $8,698,341 |
Salary | $660,000 |
Stock Awards | $3,365,750 |
Other | $11,200 |
Total | $13,153,566 |
Leschly received $8.7M in option awards, accounting for 66% of the total pay in 2019.
Leschly also received $418.3K in non-equity incentive plan, $660K in salary, $3.4M in stock awards and $11.2K in other compensation.
Rankings
In 2019, Nick Leschly's compensation ranked 445th out of 13,971 executives tracked by ExecPay. In other words, Leschly earned more than 96.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 445 out of 13,971 | 97th |
Division Manufacturing | 166 out of 5,701 | 97th |
Major group Chemicals And Allied Products | 44 out of 2,200 | 98th |
Industry group Drugs | 36 out of 1,886 | 98th |
Industry Biological Products, Except Diagnostic Substances | 7 out of 389 | 98th |
Source: SEC filing on April 27, 2020.
Leschly's colleagues
We found five more compensation records of executives who worked with Nick Leschly at bluebird bio in 2019.
News
2seventy bio CEO Nick Leschly's 2023 pay jumps 49% to $9.1M
April 25, 2024
bluebird bio CEO Andrew Obenshain receives $9.3M in 2021
May 2, 2022
2seventy bio CEO Nick Leschly's 2021 pay rises 1% to $6.3M
April 26, 2022
bluebird bio CEO Nick Leschly's 2019 pay falls 45% to $13M
April 27, 2020
bluebird bio CEO Nick Leschly's 2018 pay jumps 173% to $24M
April 23, 2019